Table 7 |
||||||
|
Summary of mRNA levels in GFP shRNA control transfectants, URE3-BP shRNA transfectants, and nontransfected HM1:IMSS trophozoites |
||||||
|
shRNA transfectant or control sample |
URE3-BP 5' oligo pair |
P-value |
URE3-BP middle oligo pair |
P-value |
URE3-BP 3' oligo pair |
P-value |
|
|
||||||
|
GFP |
100.0 ± 2.9 |
-- |
100 ± 2.8 |
-- |
100 ± 4.3 |
-- |
|
HM1:IMSS |
106.4 ± 5.8 |
0.2928 |
108.9 ± 5.6 |
0.1008 |
102.8 ± 5.0 |
0.5792 |
|
URE3-BP (350–378) |
67.0 ± 2.5 |
<0.0001 |
67.4 ± 2.0 |
<0.0001 |
72.2 ± 2.8 |
<0.0001 |
|
|
||||||
|
URE3-BP (580–608) |
12.4 ± 0.8 |
<0.0001 |
13.5 ± 3.3 |
<0.0001 |
12.5 ± 3.8 |
<0.0001 |
|
|
||||||
|
The average URE3-BP transcript level as measured by qRT-PCR and normalized to actin was defined as being 100% in the GFP shRNA control transfectants. HM1:IMSS nontransfected amebae were also included. Three different oligo pairs amplifying the 5', middle, and 3' sections of URE3-BP were used (sequences and locations are shown in Table 3). Student's t test was used for statistical analysis. Three biological replicates were each assayed in quadruplicate with each oligo pair, with the exception of the HM1:IMSS samples, which had one biological replicate. Values are expressed as the percentage of URE3-BP mRNA of the GFP control shRNA transfectant level ± SE, with the P-value following each. |
||||||
|
Linford et al. BMC Microbiology 2009 9:38 doi:10.1186/1471-2180-9-38 |
||||||